Trump executive order targets prescription drug prices
- President Trump signed an executive order in Washington on April 15, 2025.
- The White House indicated the action aims to lower prescription drug costs.
- HHS will work to standardize Medicare payments, potentially cutting patient costs by 60%.
- The order seeks to lower insulin to 3 cents and epinephrine to $15, plus a small fee.
- The order may facilitate importation and bolster state programs, HHS will seek comment on Biden's negotiation program.
12 Articles
12 Articles
Donald Trump signs a decree to lower the price of medicines
Donald Trump signed on Tuesday a decree in which he orders his government to work on a series of measures to lower the price of medicines in the United States, where they are significantly higher than abroad. ...


Soaring Medicare prescription drug prices targeted in Trump’s new executive order
President Donald Trump is seeking to combat soaring prescription drug prices in a new executive order he signed Tuesday. The order instructs Robert F. Kennedy Jr.’s Department of Health and Human Services (DHS) to standardize Medicare payments for prescription drugs — including those used for cancer patients — no matter where a patient receives treatment. This could lower prices for patients by as much as 60%, according to a White House fact sh…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage